Ozempic is the injectable peptide GLP-1 medicine with the most FDA-approved uses in type 2 diabetes, with indications to improve blood sugar along with diet and exercise, to reduce the risk of major cardiovascular events (heart attack, stroke, or death) in adults who also have known heart disease, and to reduce the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults who also have chronic kidney disease
A further four filters were developed to detect mentions of different oral medication types, specifically pills that are (i) shiny or coated, (ii) flavored, (iii) non-flavored, and (iv) soft chewables
It is likely that other agents do as well, but this area needs more research
A weight loss injection is a prescription medicine injected under the skin typically once a week that works by mimicking the GLP-1 hormone naturally produced in your gut
The TRIUMPH program includes multiple phase 3 trials, and one trial, TRIUMPH-Outcomes, is specifically designed to answer the question of whether retatrutide reduces major adverse cardiovascular events